{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:45:31Z","timestamp":1783651531797,"version":"3.55.0"},"reference-count":160,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["2020GXNSFAA297178"],"award-info":[{"award-number":["2020GXNSFAA297178"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Guangxi Natural Science Foundation","doi-asserted-by":"publisher","award":["2018GXNSFBA281083"],"award-info":[{"award-number":["2018GXNSFBA281083"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012434","name":"Basic Ability Improvement Project of Yong and Middle-aged Teachers in Guangxi Colleges and Universities","doi-asserted-by":"publisher","award":["2018KY0050"],"award-info":[{"award-number":["2018KY0050"]}],"id":[{"id":"10.13039\/501100012434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPD"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Currently, many therapeutic drugs are difficult to cross the blood-brain barrier (BBB), making it difficult to reach the site of action and thus fail to achieve the desired efficacy. In recent years, researchers and drug designers have increasingly focused on nanotechnology to break through the difficulty of small molecule inhibitors to cross the blood-brain barrier (BBB) and improve the success rate of drug delivery to the central nervous system. Among the common central neurological diseases, such as encephalitis, Parkinson's, Alzheimer's disease, and epilepsy, Alzheimer's disease has attracted much attention from researchers. Alzheimer's disease is a specific neurodegenerative disease, which causes irreversible degeneration of neurons as well as synapses in the brain, resulting in memory and cognitive dysfunction, along with other psychiatric symptoms and behavioral disorders, which seriously affects people's everyday life. Moreover, nanotechnology has excellent potential for application in AD treatment. Studies have shown that nanocarriers can target the delivery of chemotherapeutic drugs, antioxidants, and other therapeutic substances to brain tissue using existing physiological mechanisms, thus effectively alleviating the disease progression of AD. Therefore, various nanoparticles and nanomedicines have been developed and constructed for diagnosing and treating AD in the past decades, such as nanoparticles, bionanoparticles, liposomes, nano-gel, dendrimers, and self-assembled nanoparticles. This study aims to review the applications and results of nanotechnology in the treatment of Alzheimer's disease in recent years and provide some ideas and clues for future research and development of more effective drug delivery systems.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1381612829666221216114912","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T05:58:20Z","timestamp":1671429500000},"page":"95-115","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Research Progress of Nanocarriers for the Treatment of Alzheimer's Disease"],"prefix":"10.2174","volume":"29","author":[{"given":"Xu","family":"Liu","sequence":"first","affiliation":[{"name":"Medical College of Guangxi University, Guangxi University, Nanning, 530004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqing","family":"Yuan","sequence":"first","affiliation":[{"name":"Medical College of Guangxi University, Guangxi University, Nanning, 530004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Li","sequence":"additional","affiliation":[{"name":"Medical College of Guangxi University, Guangxi University, Nanning, 530004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Zhang","sequence":"additional","affiliation":[{"name":"Medical College of Guangxi University, Guangxi University, Nanning, 530004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyue","family":"Huang","sequence":"additional","affiliation":[{"name":"Medical College of Guangxi University, Guangxi University, Nanning, 530004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingguo","family":"Du","sequence":"additional","affiliation":[{"name":"Medical College of Guangxi University, Guangxi University, Nanning, 530004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Tu","sequence":"additional","affiliation":[{"name":"Medical College of Guangxi University, Guangxi University, Nanning, 530004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotian","family":"Wu","sequence":"additional","affiliation":[{"name":"Medical College of Guangxi University, Guangxi University, Nanning, 530004, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/j.1741-1130.2007.00143.x","volume":"5","author":"Vardi G.","year":"2008","unstructured":"Vardi G.; Merrick J.; Neurological disorders: Public health challenges. J Policy Pract Intell Disabil 2008,5(1),75","journal-title":"J Policy Pract Intell Disabil"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.jmb.2019.03.025","volume":"431","author":"Freude K.","year":"2019","unstructured":"Freude K.; Krauss S.; Dementia, brain disorders and molecular mechanisms. J Mol Biol 2019,431(9),1709-1710","journal-title":"J Mol Biol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"Pardridge W.M.","year":"2005","unstructured":"Pardridge W.M.; The blood-brain barrier: Bottleneck in brain drug development. NeuroRx 2005,2(1),3-14","journal-title":"NeuroRx"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.1177\/1179573517693802","volume":"9","author":"Brzica H.","year":"2017","unstructured":"Brzica H.; Abdullahi W.; Ibbotson K.; Ronaldson P.T.; Role of transporters in central nervous system drug delivery and blood-brain barrier protection: relevance to treatment of stroke. J Cent Nerv Syst Dis 2017,9","journal-title":"J Cent Nerv Syst Dis"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.4103\/2230-973X.96920","volume":"2","author":"Tiwari G.","year":"2012","unstructured":"Tiwari G.; Tiwari R.; Bannerjee S.K.; Bhati L.; Pandey S.; Pandey P.; Sriwastawa B.; Drug delivery systems: An updated review. Int J Pharm Investig 2012,2(1),2-11","journal-title":"Int J Pharm Investig"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","volume":"37","author":"Abbott N.J.","year":"2010","unstructured":"Abbott N.J.; Patabendige A.A.K.; Dolman D.E.M.; Yusof S.R.; Begley D.J.; Structure and function of the blood-brain barrier. Neurobiol Dis 2010,37(1),13-25","journal-title":"Neurobiol Dis"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fneng.2013.00007","volume":"6","author":"Wong A.D.","year":"2013","unstructured":"Wong A.D.; Ye M.; Levy A.F.; Rothstein J.D.; Bergles D.E.; Searson P.C.; The blood-brain barrier: An engineering perspective. Front Neuroeng 2013,6,7","journal-title":"Front Neuroeng"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.semcdb.2015.01.002","volume":"38","author":"Serlin Y.","year":"2015","unstructured":"Serlin Y.; Shelef I.; Knyazer B.; Friedman A.; Anatomy and physiology of the blood\u2013brain barrier. Semin Cell Dev Biol 2015,38,2-6","journal-title":"Semin Cell Dev Biol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nrn1722","volume":"6","author":"Volterra A.","year":"2005","unstructured":"Volterra A.; Meldolesi J.; Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 2005,6(8),626-640","journal-title":"Nat Rev Neurosci"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/nature05193","volume":"443","author":"Peppiatt C.M.","year":"2006","unstructured":"Peppiatt C.M.; Howarth C.; Mobbs P.; Attwell D.; Bidirectional control of CNS capillary diameter by pericytes. Nature 2006,443(7112),700-704","journal-title":"Nature"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/ca.23083","volume":"31","author":"Sharif Y.","year":"2018","unstructured":"Sharif Y.; Jumah F.; Coplan L.; Krosser A.; Sharif K.; Tubbs R.S.; Blood brain barrier: A review of its anatomy and physiology in health and disease. Clin Anat 2018,31(6),812-823","journal-title":"Clin Anat"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.apsb.2016.05.013","volume":"6","author":"Gao H.","year":"2016","unstructured":"Gao H.; Progress and perspectives on targeting nanoparticles for brain drug delivery. Acta Pharm Sin B 2016,6(4),268-286","journal-title":"Acta Pharm Sin B"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.addr.2013.08.008","volume":"71","author":"Kreuter J.","year":"2014","unstructured":"Kreuter J.; Drug delivery to the central nervous system by polymeric nanoparticles: What do we know? Adv Drug Deliv Rev 2014,71,2-14","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.2217\/nnm.12.86","volume":"7","author":"Jain K.K.","year":"2012","unstructured":"Jain K.K.; Nanobiotechnology-based strategies for crossing the blood-brain barrier. Nanomedicine (Lond) 2012,7(8),1225-1233","journal-title":"Nanomedicine (Lond)"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"e93342","DOI":"10.1371\/journal.pone.0093342","volume":"9","author":"Fischer N.O.","year":"2014","unstructured":"Fischer N.O.; Weilhammer D.R.; Dunkle A.; Thomas C.; Hwang M.; Corzett M.; Lychak C.; Mayer W.; Urbin S.; Collette N.; Chiun Chang J.; Loots G.G.; Rasley A.; Blanchette C.D.; Evaluation of nanolipoprotein particles (NLPs) as an in vivo delivery platform. PLoS One 2014,9(3),e93342","journal-title":"PLoS One"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"20549","DOI":"10.1021\/acsami.6b04609","volume":"8","author":"Gilmore S.F.","year":"2016","unstructured":"Gilmore S.F.; Blanchette C.D.; Scharadin T.M.; Hura G.L.; Rasley A.; Corzett M.; Pan C.; Fischer N.O.; Henderson P.T.; Lipid cross-linking of nanolipoprotein particles substantially enhances serum stability and cellular uptake. ACS Appl Mater Interfaces 2016,8(32),20549-20557","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.addr.2011.11.010","volume":"64","author":"Chen Y.","year":"2012","unstructured":"Chen Y.; Liu L.; Modern methods for delivery of drugs across the blood\u2013brain barrier. Adv Drug Deliv Rev 2012,64(7),640-665","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.2174\/092986710790827816","volume":"17","author":"Ueno M","year":"2010","unstructured":"Ueno M; Nakagawa T; Wu B; Transporters in the brain endothelial barrier. Curr Med Chem 2010,17(12),1125-38","journal-title":"Curr Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.2147\/IJN.S61288","volume":"9","author":"Lu C.T.","year":"2014","unstructured":"Lu C.T.; Zhao Y.Z.; Wong H.L.; Cai J.; Peng L.; Tian X.Q.; Current approaches to enhance CNS delivery of drugs across the brain barriers. Int J Nanomedicine 2014,9,2241-2257","journal-title":"Int J Nanomedicine"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"120011","DOI":"10.1016\/j.ijpharm.2020.120011","volume":"591","author":"Arduino I.","year":"2020","unstructured":"Arduino I.; Iacobazzi R.M.; Riganti C.; Lopedota A.A.; Perrone M.G.; Lopalco A.; Cutrignelli A.; Cantore M.; Laquintana V.; Franco M.; Colabufo N.A.; Luurtsema G.; Contino M.; Denora N.; Induced expression of P-gp and BCRP transporters on brain endothelial cells using transferrin functionalized nanostructured lipid carriers: A first step of a potential strategy for the treatment of Alzheimer\u2019s disease. Int J Pharm 2020,591,120011","journal-title":"Int J Pharm"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1504\/IJCBDD.2013.056801","volume":"6","author":"Shityakov S.","year":"2013","unstructured":"Shityakov S.; F&#xF6;rster C.; F&#xF6;rster C.; Multidrug resistance protein P-gp interaction with nanoparticles (fullerenes and carbon nanotube) to assess their drug delivery potential: A theoretical molecular docking study. Int J Comput Biol Drug Des 2013,6(4),343-357","journal-title":"Int J Comput Biol Drug Des"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/AABC.S56046","volume":"7","author":"Shityakov S.","year":"2014","unstructured":"Shityakov S.; Foerster C.; In silico structure-based screening of versatile P-glycoprotein inhibitors using polynomial empirical scoring functions. Adv Appl Bioinform Chem 2014,7,1-9","journal-title":"Adv Appl Bioinform Chem"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2147\/AABC.S63749","volume":"7","author":"Shityakov S.","year":"2014","unstructured":"Shityakov S.; Foerster C.; In silico predictive model to determine vector-mediated transport properties for the blood\u2013brain barrier choline transporter. Adv Appl Bioinform Chem 2014,7,23-36","journal-title":"Adv Appl Bioinform Chem"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/13813450902949012","volume":"115","author":"Laron Z.","year":"2009","unstructured":"Laron Z.; Insulin and the brain. Arch Physiol Biochem 2009,115(2),112-116","journal-title":"Arch Physiol Biochem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","volume":"235","author":"Saraiva C.","year":"2016","unstructured":"Saraiva C.; Pra&#xE7;a C.; Ferreira R.; Santos T.; Ferreira L.; Bernardino L.; Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. J Control Release 2016,235,34-47","journal-title":"J Control Release"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1021\/mp050032z","volume":"2","author":"Sahoo S.K.","year":"2005","unstructured":"Sahoo S.K.; Labhasetwar V.; Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol Pharm 2005,2(5),373-383","journal-title":"Mol Pharm"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.addr.2011.10.007","volume":"64","author":"Wong H.L.","year":"2012","unstructured":"Wong H.L.; Wu X.Y.; Bendayan R.; Nanotechnological advances for the delivery of CNS therapeutics. Adv Drug Deliv Rev 2012,64(7),686-700","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s00418-008-0448-1","volume":"130","author":"Larsen A","year":"2008","unstructured":"Larsen A; Kolind K; Pedersen DS; Gold ions bio-released from metallic gold particles reduce inflammation and apoptosis and increase the regenerative responses in focal brain injury. Histochemistry and Cell Biology 2008,130(4),681-92","journal-title":"Histochemistry and Cell Biology"},{"key":"ref=29","first-page":"573","volume":"24","author":"Pedersen M.&#xD8;.","year":"2009","unstructured":"Pedersen M.&#xD8;.; Larsen A.; Pedersen D.S.; Stoltenberg M.; Penkowa M.; Metallic gold treatment reduces proliferation of inflammatory cells, increases expression of VEGF and FGF, and stimulates cell proliferation in the subventricular zone following experimental traumatic brain injury. Histol Histopathol 2009,24(5),573-586","journal-title":"Histol Histopathol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.msec.2017.03.283","volume":"77","author":"Muller A.P.","year":"2017","unstructured":"Muller A.P.; Ferreira G.K.; Pires A.J.; de Bem Silveira G.; de Souza D.L.; Brandolfi J.A.; de Souza C.T.; Paula M.M.S.; Silveira P.C.L.; Gold nanoparticles prevent cognitive deficits, oxidative stress and inflammation in a rat model of sporadic dementia of Alzheimer\u2019s type. Mater Sci Eng C 2017,77,476-483","journal-title":"Mater Sci Eng C"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/art.22401","volume":"56","author":"Tsai C.Y.","year":"2007","unstructured":"Tsai C.Y.; Shiau A.L.; Chen S.Y.; Chen Y.H.; Cheng P.C.; Chang M.Y.; Chen D.H.; Chou C.H.; Wang C.R.; Wu C.L.; Amelioration of collagen-induced arthritis in rats by nanogold. Arthritis Rheum 2007,56(2),544-554","journal-title":"Arthritis Rheum"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jcis.2019.05.066","volume":"552","author":"Liu Y.","year":"2019","unstructured":"Liu Y.; Zhou H.; Yin T.; Gong Y.; Yuan G.; Chen L.; Liu J.; Quercetin-modified gold-palladium nanoparticles as a potential autophagy inducer for the treatment of Alzheimer\u2019s disease. J Colloid Interface Sci 2019,552,388-400","journal-title":"J Colloid Interface Sci"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1016\/j.nano.2017.06.022","volume":"13","author":"Kim M.J.","year":"2017","unstructured":"Kim M.J.; Rehman S.U.; Amin F.U.; Kim M.O.; Enhanced neuroprotection of anthocyanin-loaded PEG-gold nanoparticles against A&#x3B2;-induced neuroinflammation and neurodegeneration via the NF-B \/JNK\/GSK3&#x3B2; signaling pathway. Nanomedicine 2017,13(8),2533-2544","journal-title":"Nanomedicine"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/s10876-019-01548-1","volume":"30","author":"Sivaji K.","year":"2019","unstructured":"Sivaji K.; Kannan R.R.; Polysorbate 80 coated gold nanoparticle as a drug carrier for brain targeting in zebrafish model. J Cluster Sci 2019,30(4),897-906","journal-title":"J Cluster Sci"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1039\/C3NR04878K","volume":"6","author":"Shilo M.","year":"2014","unstructured":"Shilo M.; Motiei M.; Hana P.; Popovtzer R.; Transport of nanoparticles through the blood\u2013brain barrier for imaging and therapeutic applications. Nanoscale 2014,6(4),2146-2152","journal-title":"Nanoscale"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1039\/c0nr00875c","volume":"3","author":"Celardo I.","year":"2011","unstructured":"Celardo I.; Pedersen J.Z.; Traversa E.; Ghibelli L.; Pharmacological potential of cerium oxide nanoparticles. Nanoscale 2011,3(4),1411-1420","journal-title":"Nanoscale"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.1039\/b919677n","volume":"39","author":"Karakoti A.","year":"2010","unstructured":"Karakoti A.; Singh S.; Dowding J.M.; Seal S.; Self W.T.; Redox-active radical scavenging nanomaterials. Chem Soc Rev 2010,39(11),4422-4432","journal-title":"Chem Soc Rev"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"14144","DOI":"10.1021\/ja9051087","volume":"131","author":"Karakoti A.S.","year":"2009","unstructured":"Karakoti A.S.; Singh S.; Kumar A.; Malinska M.; Kuchibhatla S.V.N.T.; Wozniak K.; Self W.T.; Seal S.; PEGylated nanoceria as radical scavenger with tunable redox chemistry. J Am Chem Soc 2009,131(40),14144-14145","journal-title":"J Am Chem Soc"},{"key":"ref=39","first-page":"e1444","volume":"9","author":"Beverly A.R.","year":"2017","unstructured":"Beverly A.R.; Charles S.C.; Marion E.; Cerium oxide nanoparticles in neuroprotection and considerations for efficacy and safety. WIREs 2017,9(4),e1444","journal-title":"WIREs"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1021\/acsnano.5b08045","volume":"10","author":"Kwon H.J.","year":"2016","unstructured":"Kwon H.J.; Cha M.Y.; Kim D.; Kim D.K.; Soh M.; Shin K.; Hyeon T.; Mook-Jung I.; Mitochondria-targeting ceria nanoparticles as antioxidants for Alzheimer\u2019s disease. ACS Nano 2016,10(2),2860-2870","journal-title":"ACS Nano"},{"key":"ref=41","volume":"31","author":"Dokyoon K.","year":"2019","unstructured":"Dokyoon K.; Jin K.H.; Taeghwan H.; Magnetite\/ceria nanoparticle assemblies for extracorporeal cleansing of amyloid-&#x3B2; in Alzheimer's disease. Adv Mater (Deerfield Beach, Fla) 2019,31(19)","journal-title":"Adv Mater (Deerfield Beach, Fla)"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"14523","DOI":"10.1002\/chem.201603233","volume":"22","author":"Guan Y.","year":"2016","unstructured":"Guan Y.; Gao N.; Ren J.; Qu X.; Rationally designed CeNP@MnMoS core-shell nanoparticles for modulating multiple facets of Alzheimer\u2019s disease. Chemistry 2016,22(41),14523-14526","journal-title":"Chemistry"},{"key":"ref=43","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201370057","volume":"9","author":"Ling D.","year":"2013","unstructured":"Ling D.; Iron oxide nanoparticles: Chemical design of biocompatible iron oxide nanoparticles for medical applications (Small 9-10\/2013). Small 2013,9(9-10)","journal-title":"Small"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ijpharm.2014.04.038","volume":"468","author":"Anwar M.","year":"2014","unstructured":"Anwar M.; Asfer M.; Prajapati A.P.; Mohapatra S.; Akhter S.; Ali A.; Ahmad F.J.; Synthesis and in vitro localization study of curcumin-loaded SPIONs in a micro capillary for simulating a targeted drug delivery system. Int J Pharm 2014,468(1-2),158-164","journal-title":"Int J Pharm"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.biomaterials.2014.12.005","volume":"44","author":"Cheng K.K.","year":"2015","unstructured":"Cheng K.K.; Chan P.S.; Fan S.; Kwan S.M.; Yeung K.L.; W&#xE1;ng Y.X.J.; Chow A.H.L.; Wu E.X.; Baum L.; Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer\u2019s disease mice using magnetic resonance imaging (MRI). Biomaterials 2015,44,155-172","journal-title":"Biomaterials"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"e57097","DOI":"10.1371\/journal.pone.0057097","volume":"8","author":"Wadghiri Y.Z.","year":"2013","unstructured":"Wadghiri Y.Z.; Li J.; Wang J.; Hoang D.M.; Sun Y.; Xu H.; Tsui W.; Li Y.; Boutajangout A.; Wang A.; de Leon M.; Wisniewski T.; Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer\u2019s disease transgenic mice using magnetic resonance microimaging. PLoS One 2013,8(2),e57097","journal-title":"PLoS One"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"12833","DOI":"10.1021\/acsomega.9b01411","volume":"4","author":"Sonawane S.K.","year":"2019","unstructured":"Sonawane S.K.; Ahmad A.; Chinnathambi S.; Protein-capped metal nanoparticles inhibit tau aggregation in alzheimer\u2019s disease. ACS Omega 2019,4(7),12833-12840","journal-title":"ACS Omega"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2147\/IJN.S190354","volume":"14","author":"Javdani N.","year":"2019","unstructured":"Javdani N.; Rahpeyma S.S.; Ghasemi Y.; Raheb J.; Effect of superparamagnetic nanoparticles coated with various electric charges on &#x3B1;-synuclein and &#x3B2;-amyloid proteins fibrillation process. Int J Nanomedicine 2019,14,799-808","journal-title":"Int J Nanomedicine"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"19881","DOI":"10.1039\/C8NJ03541E","volume":"42","author":"Brahmkhatri V.P.","year":"2018","unstructured":"Brahmkhatri V.P.; Sharma N.; Sunanda P.; D\u2019Souza A.; Raghothama S.; Atreya H.S.; Curcumin nanoconjugate inhibits aggregation of N-terminal region (A&#x3B2;-16) of an amyloid beta peptide. New J Chem 2018,42(24),19881-19892","journal-title":"New J Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1700384","DOI":"10.1002\/ppsc.201700384","volume":"35","author":"Li C.","year":"2018","unstructured":"Li C.; Lu J.; Hu X.; Feng C.; Xiang Y.; Karamanos Y.; Li G.; Assembly of nanoconjugates as new kind inhibitor of the aggregation of amyloid peptides associated with Alzheimer\u2019s disease. Part Part Syst Charact 2018,35(3),1700384","journal-title":"Part Part Syst Charact"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"9972","DOI":"10.1039\/c1cc11760b","volume":"47","author":"Wu S.H.","year":"2011","unstructured":"Wu S.H.; Hung Y.; Mou C.Y.; Mesoporous silica nanoparticles as nanocarriers. Chem Commun (Camb) 2011,47(36),9972-9985","journal-title":"Chem Commun (Camb)"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"17944","DOI":"10.1021\/acsami.6b05834","volume":"8","author":"Lin Y.H.","year":"2016","unstructured":"Lin Y.H.; Chen Y.P.; Liu T.P.; Chien F.C.; Chou C.M.; Chen C.T.; Mou C.Y.; Approach to deliver two antioxidant enzymes with mesoporous silica nanoparticles into cells. ACS Appl Mater Interfaces 2016,8(28),17944-17954","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"4785","DOI":"10.1002\/smll.201401559","volume":"10","author":"Chang F.P.","year":"2014","unstructured":"Chang F.P.; Chen Y.P.; Mou C.Y.; Intracellular implantation of enzymes in hollow silica nanospheres for protein therapy: cascade system of superoxide dismutase and catalase. Small 2014,10(22),4785-4795","journal-title":"Small"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.biomaterials.2017.01.006","volume":"121","author":"Liu X.","year":"2017","unstructured":"Liu X.; Sui B.; Sun J.; Blood-brain barrier dysfunction induced by silica NPs in vitro and in vivo:Involvement of oxidative stress and Rho-kinase\/JNK signaling pathways. Biomaterials 2017,121,64-82","journal-title":"Biomaterials"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1002\/jnr.22309","volume":"88","author":"Cho Y.","year":"2010","unstructured":"Cho Y.; Shi R.; Ivanisevic A.; Ben Borgens R.; Functional silica nanoparticle-mediated neuronal membrane sealing following traumatic spinal cord injury. J Neurosci Res 2010,88(7),1433-1444","journal-title":"J Neurosci Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1139\/cjpp-2018-0401","volume":"97","author":"Ye Y.","year":"2019","unstructured":"Ye Y.; Hui L.; Lakpa K.L.; Xing Y.; Wollenzien H.; Chen X.; Zhao J.X.; Geiger J.D.; Effects of silica nanoparticles on endolysosome function in primary cultured neurons. Can J Physiol Pharmacol 2019,97(4),297-305","journal-title":"Can J Physiol Pharmacol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"15322","DOI":"10.1021\/acsami.9b02797","volume":"11","author":"Cheng C.S.","year":"2019","unstructured":"Cheng C.S.; Liu T.P.; Chien F.C.; Mou C.Y.; Wu S.H.; Chen Y.P.; Codelivery of plasmid and curcumin with mesoporous silica nanoparticles for promoting neurite outgrowth. ACS Appl Mater Interfaces 2019,11(17),15322-15331","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jinorgbio.2016.04.017","volume":"163","author":"Halevas E.","year":"2016","unstructured":"Halevas E.; Nday C.M.; Salifoglou A.; Hybrid catechin silica nanoparticle influence on Cu(II) toxicity and morphological lesions in primary neuronal cells. J Inorg Biochem 2016,163,240-249","journal-title":"J Inorg Biochem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s11671-008-9140-6","volume":"3","author":"Deshpande A.S.","year":"2008","unstructured":"Deshpande A.S.; Khomane R.B.; Vaidya B.K.; Joshi R.M.; Harle A.S.; Kulkarni B.D.; Sulfur nanoparticles synthesis and characterization from HS gas, using novel biodegradable iron chelates in W\/O microemulsion. Nanoscale Res Lett 2008,3(6),221","journal-title":"Nanoscale Res Lett"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.jbiosc.2020.01.004","volume":"129","author":"Moura C.S.","year":"2020","unstructured":"Moura C.S.; Silva J.C.; Faria S.; Fernandes P.R.; da Silva C.L.; Cabral J.M.S.; Linhardt R.; B&#xE1;rtolo P.J.; Ferreira F.C.; Chondrogenic differentiation of mesenchymal stem\/stromal cells on 3D porous poly (&#x3B5;-caprolactone) scaffolds: Effects of material alkaline treatment and chondroitin sulfate supplementation. J Biosci Bioeng 2020,129(6),756-764","journal-title":"J Biosci Bioeng"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1007\/s11064-015-1628-8","volume":"40","author":"Ju C.","year":"2015","unstructured":"Ju C.; Hou L.; Sun F.; Zhang L.; Zhang Z.; Gao H.; Wang L.; Wang D.; Lv Y.; Zhao X.; Anti-oxidation and antiapoptotic effects of chondroitin sulfate on 6-hydroxydopamine-induced injury through the up-regulation of nrf2 and inhibition of mitochondria-mediated pathway. Neurochem Res 2015,40(7),1509-1519","journal-title":"Neurochem Res"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1021\/acsbiomaterials.6b00805","volume":"3","author":"Betancur M.I.","year":"2017","unstructured":"Betancur M.I.; Mason H.D.; Alvarado-Velez M.; Holmes P.V.; Bellamkonda R.V.; Karumbaiah L.; Chondroitin sulfate glycosaminoglycan matrices promote neural stem cell maintenance and neuroprotection post-traumatic brain injury. ACS Biomater Sci Eng 2017,3(3),420-430","journal-title":"ACS Biomater Sci Eng"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"7756","DOI":"10.1039\/C9TB01984G","volume":"7","author":"Li Y.M.","year":"2019","unstructured":"Li Y.M.; Wu J.Y.; Jiang J.; Dong S.K.; Chen Y.S.; He H.Y.; Liu C.S.; Zhao J.Z.; Chondroitin sulfate-polydopamine modified polyethylene terephthalate with extracellular matrix-mimetic immunoregulatory functions for osseointegration. J Mater Chem B Mater Biol Med 2019,7(48),7756-7770","journal-title":"J Mater Chem B Mater Biol Med"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1124\/jpet.107.123505","volume":"323","author":"Ca&#xF1;as N.","year":"2007","unstructured":"Ca&#xF1;as N.; Valero T.; Villarroya M.; Montell E.; Verg&#xE9;s J.; Garc&#xED;a A.G.; L&#xF3;pez M.G.; Chondroitin sulfate protects SH-SY5Y cells from oxidative stress by inducing heme oxygenase-1 via phosphatidylinositol 3-kinase\/Akt. J Pharmacol Exp Ther 2007,323(3),946-953","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1021\/acschemneuro.7b00312","volume":"9","author":"Sun J.","year":"2018","unstructured":"Sun J.; Xie W.; Zhu X.; Xu M.; Liu J.; Sulfur nanoparticles with novel morphologies coupled with brain-targeting peptides RVG as a new type of inhibitor against metal-induced a&#x3B2; aggregation. ACS Chem Neurosci 2018,9(4),749-761","journal-title":"ACS Chem Neurosci"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"6498","DOI":"10.1039\/C9NR09713A","volume":"12","author":"Liu Y.","year":"2020","unstructured":"Liu Y.; Gong Y.; Xie W.; Huang A.; Yuan X.; Zhou H.; Zhu X.; Chen X.; Liu J.; Liu J.; Qin X.; Microbubbles in combination with focused ultrasound for the delivery of quercetin-modified sulfur nanoparticles through the blood brain barrier into the brain parenchyma and relief of endoplasmic reticulum stress to treat Alzheimer\u2019s disease. Nanoscale 2020,12(11),6498-6511","journal-title":"Nanoscale"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.ijbiomac.2019.09.098","volume":"142","author":"Gao F.","year":"2020","unstructured":"Gao F.; Zhao J.; Liu P.; Ji D.; Zhang L.; Zhang M.; Li Y.; Xiao Y.; Preparation and in vitro evaluation of multi-target-directed selenium-chondroitin sulfate nanoparticles in protecting against the Alzheimer\u2019s disease. Int J Biol Macromol 2020,142,265-276","journal-title":"Int J Biol Macromol"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijbiomac.2020.03.079","volume":"154","author":"Ji D.","year":"2020","unstructured":"Ji D.; Wu X.; Li D.; Protective effects of chondroitin sulphate nano-selenium on a mouse model of Alzheimer\u2019s disease. Int J Biol Macromol 2020,154,233-245","journal-title":"Int J Biol Macromol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","volume":"161","author":"Danhier F.","year":"2012","unstructured":"Danhier F.; Ansorena E.; Silva J.M.; Coco R.; Le Breton A.; Pr&#xE9;at V.; PLGA-based nanoparticles: An overview of biomedical applications. J Control Release 2012,161(2),505-522","journal-title":"J Control Release"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.jbiotec.2011.07.020","volume":"156","author":"Brambilla D.","year":"2011","unstructured":"Brambilla D.; Souguir H.; Nicolas J.; Mackiewicz N.; Verpillot R.; Le Droumaguet B.; Taverna M.; Couvreur P.; Andrieux K.; Colloidal properties of biodegradable nanoparticles influence interaction with amyloid-&#x3B2; peptide. J Biotechnol 2011,156(4),338-340","journal-title":"J Biotechnol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2016.01.055","volume":"226","author":"Yao L.","year":"2016","unstructured":"Yao L.; Gu X.; Song Q.; Wang X.; Huang M.; Hu M.; Hou L.; Kang T.; Chen J.; Chen H.; Gao X.; Nanoformulated alpha-mangostin ameliorates Alzheimer\u2019s disease neuropathology by elevating LDLR expression and accelerating amyloid-beta clearance. J Control Release 2016,226,1-14","journal-title":"J Control Release"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1021\/bc400055h","volume":"24","author":"Liu Z.","year":"2013","unstructured":"Liu Z.; Gao X.; Kang T.; Jiang M.; Miao D.; Gu G.; Hu Q.; Song Q.; Yao L.; Tu Y.; Chen H.; Jiang X.; Chen J.; B6 peptide-modified PEG-PLA nanoparticles for enhanced brain delivery of neuroprotective peptide. Bioconjug Chem 2013,24(6),997-1007","journal-title":"Bioconjug Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.jphotobiol.2018.11.008","volume":"190","author":"Huo X.","year":"2019","unstructured":"Huo X.; Zhang Y.; Jin X.; Li Y.; Zhang L.; A novel synthesis of selenium nanoparticles encapsulated PLGA nanospheres with curcumin molecules for the inhibition of amyloid &#x3B2; aggregation in Alzheimer\u2019s disease. J Photochem Photobiol B 2019,190,98-102","journal-title":"J Photochem Photobiol B"},{"key":"ref=74","volume":"7","author":"Anila M.","year":"2012","unstructured":"Anila M.; Takahiro F.; Yutaka N.; Sakthi. Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer\u2019s disease. PLoS One 2012,7(3)","journal-title":"PLoS One"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.msec.2018.05.062","volume":"91","author":"Kuo Y-C.","year":"2018","unstructured":"Kuo Y-C.; Tsai H-C.; Rosmarinic acid- and curcumin-loaded polyacrylamide-cardiolipin-poly(lactide-co-glycolide) nanoparticles with conjugated 83-14 monoclonal antibody to protect &#x3B2;-amyloid-insulted neurons. Mater Sci Eng C 2018,91,445-457","journal-title":"Mater Sci Eng C"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.2147\/IJN.S171490","volume":"13","author":"Silva-Abreu M.","year":"2018","unstructured":"Silva-Abreu M.; Calpena A.C.; Andr&#xE9;s-Benito P.; Aso E.; Romero I.A.; Roig-Carles D.; Gromnicova R.; Espina M.; Ferrer I.; Garc&#xED;a M.L.; Male D.; PPAR&#x3B3; agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer\u2019s disease: in vitro and in vivo studies. Int J Nanomedicine 2018,13,5577-5590","journal-title":"Int J Nanomedicine"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.nano.2019.02.004","volume":"17","author":"Jeon S.G.","year":"2019","unstructured":"Jeon S.G.; Cha M.Y.; Kim J.; Hwang T.W.; Kim K.A.; Kim T.H.; Song K.C.; Kim J.J.; Moon M.; Vitamin D-binding protein-loaded PLGA nanoparticles suppress Alzheimer\u2019s disease-related pathology in 5XFAD mice. Nanomedicine 2019,17,297-307","journal-title":"Nanomedicine"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.2174\/1389450121666200615150039","volume":"21","author":"Lachowicz M.","year":"2020","unstructured":"Lachowicz M.; Sta\u0144czak A.; Ko\u0142odziejczyk M.; Characteristic of cyclodextrins: Their role and use in the pharmaceutical technology. Curr Drug Targets 2020,21(14),1495-1510","journal-title":"Curr Drug Targets"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.2147\/IJN.S31373","volume":"7","author":"Shityakov S.","year":"2012","unstructured":"Shityakov S.; Broscheit J.; F&#xF6;rster C.; &#x3B1;-Cyclodextrin dimer complexes of dopamine and levodopa derivatives to assess drug delivery to the central nervous system: ADME and molecular docking studies. Int J Nanomedicine 2012,7,3211-3219","journal-title":"Int J Nanomedicine"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"10264","DOI":"10.3390\/molecules200610264","volume":"20","author":"Shityakov S.","year":"2015","unstructured":"Shityakov S.; Pusk&#xE1;s I.; P&#xE1;pai K.; Salvador E.; Roewer N.; F&#xF6;rster C.; Broscheit J.A.; Sevoflurane-sulfobutylether-&#x3B2;-cyclodextrin complex: Preparation, characterization, cellular toxicity, molecular modeling and blood-brain barrier transport studies. Molecules 2015,20(6),10264-10279","journal-title":"Molecules"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"16861","DOI":"10.3390\/molecules191016861","volume":"19","author":"Shityakov S.","year":"2014","unstructured":"Shityakov S.; Sohajda T.; Pusk&#xE1;s I.; Roewer N.; F&#xF6;rster C.; Broscheit J.A.; Ionization states, cellular toxicity and molecular modeling studies of midazolam complexed with trimethyl-&#x3B2;-cyclodextrin. Molecules 2014,19(10),16861-16876","journal-title":"Molecules"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.ijbiomac.2017.07.087","volume":"105","author":"Muxika A.","year":"2017","unstructured":"Muxika A.; Etxabide A.; Uranga J.; Guerrero P.; de la Caba K.; Chitosan as a bioactive polymer: Processing, properties and applications. Int J Biol Macromol 2017,105(Pt 2),1358-1368","journal-title":"Int J Biol Macromol"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1007\/s43440-019-00017-w","volume":"72","author":"Heydari S.","year":"2020","unstructured":"Heydari S.; Hedayati Ch M.; Saadat F.; Abedinzade M.; Nikokar I.; Aboutaleb E.; Khafri A.; Mokarram A.R.; Diphtheria toxoid nanoparticles improve learning and memory impairment in animal model of Alzheimer\u2019s disease. Pharmacol Rep 2020,72(4),814-826","journal-title":"Pharmacol Rep"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.carbpol.2017.11.075","volume":"181","author":"Lauzon M.A.","year":"2018","unstructured":"Lauzon M.A.; Marcos B.; Faucheux N.; Characterization of alginate\/chitosan-based nanoparticles and mathematical modeling of their SpBMP-9 release inducing neuronal differentiation of human SH-SY5Y cells. Carbohydr Polym 2018,181,801-811","journal-title":"Carbohydr Polym"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","volume":"50","author":"M&#xFC;ller R.H.","year":"2000","unstructured":"M&#xFC;ller R.H.; M&#xE4;der K.; Gohla S.; Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur J Pharm Biopharm 2000,50(1),161-177","journal-title":"Eur J Pharm Biopharm"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1208\/s12249-010-9563-0","volume":"12","author":"Das S.","year":"2011","unstructured":"Das S.; Chaudhury A.; Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery. AAPS PharmSciTech 2011,12(1),62-76","journal-title":"AAPS PharmSciTech"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"107082","DOI":"10.1016\/j.nlm.2019.107082","volume":"166","author":"Dara T.","year":"2019","unstructured":"Dara T.; Vatanara A.; Sharifzadeh M.; Khani S.; Vakilinezhad M.A.; Vakhshiteh F.; Nabi Meybodi M.; Sadegh Malvajerd S.; Hassani S.; Mosaddegh M.H.; Improvement of memory deficits in the rat model of Alzheimer\u2019s disease by erythropoietin-loaded solid lipid nanoparticles. Neurobiol Learn Mem 2019,166,107082","journal-title":"Neurobiol Learn Mem"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s40199-018-0221-5","volume":"26","author":"Vakilinezhad M.A.","year":"2018","unstructured":"Vakilinezhad M.A.; Amini A.; Akbari Javar H.; Baha\u2019addini Beigi Zarandi B.F.; Montaseri H.; Dinarvand R.; Nicotinamide loaded functionalized solid lipid nanoparticles improves cognition in Alzheimer\u2019s disease animal model by reducing Tau hyperphosphorylation. Daru 2018,26(2),165-177","journal-title":"Daru"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/molecules22020277","volume":"22","author":"Loureiro J.","year":"2017","unstructured":"Loureiro J.; Andrade S.; Duarte A.; Neves A.; Queiroz J.; Nunes C.; Sevin E.; Fenart L.; Gosselet F.; Coelho M.; Pereira M.; Resveratrol and grape extract-loaded solid lipid nanoparticles for the treatment of Alzheimer\u2019s disease. Molecules 2017,22(2),277","journal-title":"Molecules"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.lfs.2018.03.010","volume":"199","author":"Rishitha N.","year":"2018","unstructured":"Rishitha N.; Muthuraman A.; Therapeutic evaluation of solid lipid nanoparticle of quercetin in pentylenetetrazole induced cognitive impairment of zebrafish. Life Sci 2018,199,80-87","journal-title":"Life Sci"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3109\/1061186X.2012.747529","volume":"21","author":"Yusuf M.","year":"2013","unstructured":"Yusuf M.; Khan M.; Khan R.A.; Ahmed B.; Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer\u2019s disease model. J Drug Target 2013,21(3),300-311","journal-title":"J Drug Target"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1080\/08982104.2017.1349143","volume":"28","author":"Malekpour-Galogahi F.","year":"2018","unstructured":"Malekpour-Galogahi F.; Hatamian-Zarmi A.; Ganji F.; Ebrahimi-Hosseinzadeh B.; Nojoki F.; Sahraeian R.; Mokhtari-Hosseini Z.B.; Preparation and optimization of rivastigmine-loaded tocopherol succinate-based solid lipid nanoparticles. J Liposome Res 2018,28(3),226-235","journal-title":"J Liposome Res"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/j.1755-5949.2010.00199.x","volume":"17","author":"Craparo E.F.","year":"2011","unstructured":"Craparo E.F.; Bond&#xEC; M.L.; Pitarresi G.; Cavallaro G.; Nanoparticulate systems for drug delivery and targeting to the central nervous system. CNS Neurosci Ther 2011,17(6),670-677","journal-title":"CNS Neurosci Ther"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.nbd.2009.07.028","volume":"37","author":"Gabathuler R.","year":"2010","unstructured":"Gabathuler R.; Approaches to transport therapeutic drugs across the blood\u2013brain barrier to treat brain diseases. Neurobiol Dis 2010,37(1),48-57","journal-title":"Neurobiol Dis"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.phrs.2010.02.004","volume":"62","author":"Fernandes C.","year":"2010","unstructured":"Fernandes C.; Soni U.; Patravale V.; Nano-interventions for neurodegenerative disorders. Pharmacol Res 2010,62(2),166-178","journal-title":"Pharmacol Res"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"305","DOI":"10.15171\/apb.2015.043","volume":"5","author":"Naseri N.","year":"2015","unstructured":"Naseri N.; Valizadeh H.; Zakeri-Milani P.; Solid lipid nanoparticles and nanostructured lipid carriers: Structure, preparation and application. Adv Pharm Bull 2015,5(3),305-313","journal-title":"Adv Pharm Bull"},{"key":"ref=97","first-page":"134","author":"Meng F.","year":"2015","unstructured":"Meng F.; Asghar S.; Gao S.; Su Z.; Song J.; Huo M.; Meng W.; Ping Q.; Xiao Y.; A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer\u2019s disease. Colloids Surf B Biointerfaces 2015,134","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3233\/JAD-190083","volume":"69","author":"Sadegh Malvajerd S.","year":"2019","unstructured":"Sadegh Malvajerd S.; Izadi Z.; Azadi A.; Kurd M.; Derakhshankhah H.; Sharifzadeh M.; Akbari Javar H.; Hamidi M.; Neuroprotective potential of curcumin-loaded nanostructured lipid carrier in an animal model of Alzheimer\u2019s disease: Behavioral and biochemical evidence. J Alzheimers Dis 2019,69(3),671-686","journal-title":"J Alzheimers Dis"},{"key":"ref=99","first-page":"207","volume":"45","author":"Gifty M.","year":"2019","unstructured":"Gifty M.; Jojo. ; Kuppusamy G.; Anindita De V. V. S.; Karri N.R.; Formulation and optimization of intranasal nanolipid carriers of pioglitazone for the repurposing in Alzheimer\u2019s disease using Box-Behnken design. Drug Dev Ind Pharm 2019,45(7),207-222","journal-title":"Drug Dev Ind Pharm"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.ijbiomac.2020.02.041","volume":"149","author":"Singh A.","year":"2020","unstructured":"Singh A.; Kumar A.; Verma R.K.; Shukla R.; Silymarin encapsulated nanoliquid crystals for improved activity against beta amyloid induced cytotoxicity. Int J Biol Macromol 2020,149,1198-1206","journal-title":"Int J Biol Macromol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"105314","DOI":"10.1016\/j.ejps.2020.105314","volume":"148","author":"Pinheiro R.G.R.","year":"2020","unstructured":"Pinheiro R.G.R.; Granja A.; Loureiro J.A.; Pereira M.C.; Pinheiro M.; Neves A.R.; Reis S.; Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer\u2019s disease. Eur J Pharm Sci 2020,148,105314","journal-title":"Eur J Pharm Sci"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1016\/j.xphs.2017.08.024","volume":"106","author":"Wavikar P.","year":"2017","unstructured":"Wavikar P.; Pai R.; Vavia P.; Nose to brain delivery of rivastigmine by in situ gelling cationic nanostructured lipid carriers: Enhanced brain distribution and pharmacodynamics. J Pharm Sci 2017,106(12),3613-3622","journal-title":"J Pharm Sci"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"8507","DOI":"10.2147\/IJN.S183117","volume":"13","author":"Ross C.","year":"2018","unstructured":"Ross C.; Taylor M.; Fullwood N.; Allsop D.; Liposome delivery systems for the treatment of Alzheimer\u2019s disease. Int J Nanomedicine 2018,13,8507-8522","journal-title":"Int J Nanomedicine"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"6938","DOI":"10.1038\/s41598-020-63894-9","volume":"10","author":"Mohammad H.","year":"2020","unstructured":"Mohammad H.;  Liposomal drug delivery of Aphanamixis polystachya leaf extracts and its neurobehavioral activity in mice model 2020,10(1),6938","journal-title":"Liposomal drug delivery of Aphanamixis polystachya leaf extracts and its neurobehavioral activity in mice model"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1080\/1061186X.2020.1761819","volume":"28","author":"Kuo Y.C.","year":"2020","unstructured":"Kuo Y.C.; Lou Y.I.; Rajesh R.; Dual functional liposomes carrying antioxidants against tau hyperphosphorylation and apoptosis of neurons. J Drug Target 2020,28(9),949-960","journal-title":"J Drug Target"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1021\/acschemneuro.0c00076","volume":"11","author":"Arora S.","year":"2020","unstructured":"Arora S.; Sharma D.; Singh J.; GLUT-1: An effective target to deliver brain-derived neurotrophic factor gene across the blood brain barrier. ACS Chem Neurosci 2020,11(11),1620-1633","journal-title":"ACS Chem Neurosci"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1021\/acs.molpharmaceut.0c00218","volume":"17","author":"Rodrigues B.S.","year":"2020","unstructured":"Rodrigues B.S.; Kanekiyo T.; Singh J.; Nerve growth factor gene delivery across the blood\u2013brain barrier to reduce beta amyloid accumulation in ad mice. Mol Pharm 2020,17(6),2054-2063","journal-title":"Mol Pharm"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.2147\/IJN.S161563","volume":"13","author":"Binda A.","year":"2018","unstructured":"Binda A.; Panariti A.; Barbuti A.; Murano C.; Dal Magro R.; Masserini M.; Re F.; Rivolta I.; Modulation of the intrinsic neuronal excitability by multifunctional liposomes tailored for the treatment of Alzheimer\u2019s disease. Int J Nanomedicine 2018,13,4059-4071","journal-title":"Int J Nanomedicine"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.actbio.2019.01.065","volume":"87","author":"Kuo Y.C.","year":"2019","unstructured":"Kuo Y.C.; Chen C.L.; Rajesh R.; Optimized liposomes with transactivator of transcription peptide and anti-apoptotic drugs to target hippocampal neurons and prevent tau-hyperphosphorylated neurodegeneration. Acta Biomater 2019,87,207-222","journal-title":"Acta Biomater"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.colsurfb.2017.11.023","volume":"161","author":"Aliakbari F.","year":"2018","unstructured":"Aliakbari F.; Shabani A.A.; Bardania H.; Mohammad-Beigi H.; Tayaranian Marvian A.; Dehghani Esmatabad F.; Vafaei A.A.; Shojaosadati S.A.; Saboury A.A.; Christiansen G.; Otzen D.E.; Morshedi D.; Formulation and anti-neurotoxic activity of baicalein-incorporating neutral nanoliposome. Colloids Surf B Biointerfaces 2018,161,578-587","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.biomaterials.2016.07.027","volume":"112","author":"Ord&#xF3;&#xF1;ez-Guti&#xE9;rrez L.","year":"2017","unstructured":"Ord&#xF3;&#xF1;ez-Guti&#xE9;rrez L.; Posado-Fern&#xE1;ndez A.; Ahmadvand D.; Lettiero B.; Wu L.; Ant&#xF3;n M.; Flores O.; Moghimi S.M.; Wandosell F.; ImmunoPEGliposome-mediated reduction of blood and brain amyloid levels in a mouse model of Alzheimer\u2019s disease is restricted to aged animals. Biomaterials 2017,112,141-152","journal-title":"Biomaterials"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"6578","DOI":"10.1021\/acs.chemmater.7b01979","volume":"29","author":"Saei A.A.","year":"2017","unstructured":"Saei A.A.; Yazdani M.; Lohse S.E.; Bakhtiary Z.; Serpooshan V.; Ghavami M.; Asadian M.; Mashaghi S.; Dreaden E.C.; Mashaghi A.; Mahmoudi M.; Nanoparticle surface functionality dictates cellular and systemic toxicity. Chem Mater 2017,29(16),6578-6595","journal-title":"Chem Mater"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1089\/ars.2016.6954","volume":"26","author":"Kuhn V.","year":"2017","unstructured":"Kuhn V.; Diederich L.; Keller T.C.S.; Kramer C.M.; L&#xFC;ckst&#xE4;dt W.; Panknin C.; Suvorava T.; Isakson B.E.; Kelm M.; Cortese-Krott M.M.; Red blood cell function and dysfunction: Redox regulation, nitric oxide metabolism, anemia. Antioxid Redox Signal 2017,26(13),718-742","journal-title":"Antioxid Redox Signal"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1128\/IAI.01426-15","volume":"84","author":"Ayi K.","year":"2016","unstructured":"Ayi K.; Lu Z.; Serghides L.; Ho J.M.; Finney C.; Wang J.C.Y.; Liles W.C.; Kain K.C.; CD47-SIRP&#x3B1; interactions regulate macrophage uptake of plasmodium falciparum-infected erythrocytes and clearance of malaria in vivo. Infect Immun 2016,84(7),2002-2011","journal-title":"Infect Immun"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.actbio.2020.03.029","volume":"108","author":"Gao C.","year":"2020","unstructured":"Gao C.; Wang Y.; Sun J.; Han Y.; Gong W.; Li Y.; Feng Y.; Wang H.; Yang M.; Li Z.; Yang Y.; Gao C.; Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer\u2019s disease mice. Acta Biomater 2020,108,285-299","journal-title":"Acta Biomater"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1080\/10717544.2020.1745328","volume":"27","author":"Han Y.","year":"2020","unstructured":"Han Y.; Chu X.; Cui L.; Fu S.; Gao C.; Li Y.; Sun B.; Neuronal mitochondria-targeted therapy for Alzheimer\u2019s disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems. Drug Deliv 2020,27(1),502-518","journal-title":"Drug Deliv"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jconrel.2015.11.009","volume":"240","author":"Soni K.S.","year":"2016","unstructured":"Soni K.S.; Desale S.S.; Bronich T.K.; Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation. J Control Release 2016,240,109-126","journal-title":"J Control Release"},{"key":"ref=118","volume":"24","author":"Iordana N.","year":"2017","unstructured":"Iordana N.; Gabriela R.A.; Alina D.; Elena N.L.; Chiriac A.P.; Basic concepts and recent advances in nano-gels as carriers for medical applications. Drug Deliv [J].2017,24(1)","journal-title":"Drug Deliv"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.addr.2015.10.004","volume":"95","author":"Tahara Y.","year":"2015","unstructured":"Tahara Y.; Akiyoshi K.; Current advances in self-assembled nanogel delivery systems for immunotherapy. Adv Drug Deliv Rev 2015,95,65-76","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.drudis.2018.05.018","volume":"23","author":"Vashist A.","year":"2018","unstructured":"Vashist A.; Kaushik A.; Vashist A.; Bala J.; Nikkhah-Moshaie R.; Sagar V.; Nair M.; Nanogels as potential drug nanocarriers for CNS drug delivery. Drug Discov Today 2018,23(7),1436-1443","journal-title":"Drug Discov Today"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"6161","DOI":"10.1039\/C5CS00199D","volume":"44","author":"Molina M.","year":"2015","unstructured":"Molina M.; Asadian-Birjand M.; Balach J.; Bergueiro J.; Miceli E.; Calder&#xF3;n M.; Stimuli-responsive nanogel composites and their application in nanomedicine. Chem Soc Rev 2015,44(17),6161-6186","journal-title":"Chem Soc Rev"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1021\/acs.langmuir.8b01921","volume":"35","author":"Zhao G.","year":"2019","unstructured":"Zhao G.; Dong X.; Sun Y.; Self-assembled curcumin\u2013poly(carboxybetaine methacrylate) conjugates: Potent nano-inhibitors against amyloid &#x3B2;-protein fibrillogenesis and cytotoxicity. Langmuir 2019,35(5),1846-1857","journal-title":"Langmuir"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nrn3209","volume":"13","author":"Fernandez A.M.","year":"2012","unstructured":"Fernandez A.M.; Torres-Alem&#xE1;n I.; The many faces of insulin-like peptide signalling in the brain. Nat Rev Neurosci 2012,13(4),225-239","journal-title":"Nat Rev Neurosci"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0303-7207(01)00455-5","volume":"177","author":"Zhao W.Q.","year":"2001","unstructured":"Zhao W.Q.; Alkon D.L.; Role of insulin and insulin receptor in learning and memory. Mol Cell Endocrinol 2001,177(1-2),125-134","journal-title":"Mol Cell Endocrinol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/j.psyneuen.2004.04.003","volume":"29","author":"Benedict C.","year":"2004","unstructured":"Benedict C.; Hallschmid M.; Hatke A.; Schultes B.; Fehm H.L.; Born J.; Kern W.; Intranasal insulin improves memory in humans. Psychoneuroendocrinology 2004,29(10),1326-1334","journal-title":"Psychoneuroendocrinology"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3233\/JAD-141791","volume":"44","author":"Claxton A.","year":"2015","unstructured":"Claxton A.; Baker L.D.; Hanson A.; Trittschuh E.H.; Cholerton B.; Morgan A.; Callaghan M.; Arbuckle M.; Behl C.; Craft S.; Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer\u2019s disease dementia. J Alzheimers Dis 2015,44(3),897-906","journal-title":"J Alzheimers Dis"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.biomaterials.2015.11.057","volume":"80","author":"Picone P.","year":"2016","unstructured":"Picone P.; Ditta L.A.; Sabatino M.A.; Militello V.; San Biagio P.L.; Di Giacinto M.L.; Cristaldi L.; Nuzzo D.; Dispenza C.; Giacomazza D.; Di Carlo M.; Ionizing radiation-engineered nanogels as insulin nanocarriers for the development of a new strategy for the treatment of Alzheimer\u2019s disease. Biomaterials 2016,80,179-194","journal-title":"Biomaterials"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jconrel.2017.11.040","volume":"270","author":"Picone P.","year":"2018","unstructured":"Picone P.; Sabatino M.A.; Ditta L.A.; Amato A.; San Biagio P.L.; Mul&#xE8; F.; Giacomazza D.; Dispenza C.; Di Carlo M.; Nose-to-brain delivery of insulin enhanced by a nanogel carrier. J Control Release 2018,270,23-36","journal-title":"J Control Release"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"170","DOI":"10.4103\/2277-9175.190942","volume":"5","author":"Mohsenifar A.","year":"2016","unstructured":"Mohsenifar A.; Nazem H.; Majdi S.; Chitosan-myristate nanogel as an artificial chaperone protects neuroserpin from misfolding. Adv Biomed Res 2016,5(1),170","journal-title":"Adv Biomed Res"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1042\/BST0350061","volume":"35","author":"Tomalia D.A.","year":"2007","unstructured":"Tomalia D.A.; Reyna L.A.; Svenson S.; Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem Soc Trans 2007,35(1),61-67","journal-title":"Biochem Soc Trans"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4103\/0975-7406.130965","volume":"6","author":"Pandita D.","year":"2014","unstructured":"Pandita D.; Poonia N.; Kumar S.; Lather V.; Madaan K.; Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues. J Pharm Bioallied Sci 2014,6(3),139-150","journal-title":"J Pharm Bioallied Sci"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1208\/s12249-020-01652-w","volume":"21","author":"Igart&#xFA;a D.E.","year":"2020","unstructured":"Igart&#xFA;a D.E.; Martinez C.S.; Del V Alonso S.; Prieto M.J.; Prieto M.J.; Combined therapy for alzheimer\u2019s disease: tacrine and pamam dendrimers co-administration reduces the side effects of the drug without modifying its activity. AAPS PharmSciTech 2020,21(3),110","journal-title":"AAPS PharmSciTech"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"14681","DOI":"10.1021\/acs.langmuir.9b02527","volume":"35","author":"Wang Z.","year":"2019","unstructured":"Wang Z.; Dong X.; Sun Y.; Mixed carboxyl and hydrophobic dendrimer surface inhibits amyloid-&#x3B2; fibrillation: new insight from the generation number effect. Langmuir 2019,35(45),14681-14687","journal-title":"Langmuir"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1021\/acschemneuro.9b00286","volume":"10","author":"Gothwal A.","year":"2019","unstructured":"Gothwal A.; Singh H.; Jain S.K.; Dutta A.; Borah A.; Gupta U.; Behavioral and biochemical implications of dendrimeric rivastigmine in memory-deficit and alzheimer\u2019s induced rodents. ACS Chem Neurosci 2019,10(8),3789-3795","journal-title":"ACS Chem Neurosci"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"10801","DOI":"10.1021\/acsnano.5b03124","volume":"9","author":"Huang M.","year":"2015","unstructured":"Huang M.; Hu M.; Song Q.; Song H.; Huang J.; Gu X.; Wang X.; Chen J.; Kang T.; Feng X.; Jiang D.; Zheng G.; Chen H.; Gao X.; GM1-modified lipoprotein-like nanoparticle: multifunctional nanoplatform for the combination therapy of alzheimer\u2019s disease. ACS Nano 2015,9(11),10801-10816","journal-title":"ACS Nano"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.ijbiomac.2018.11.224","volume":"124","author":"AnjiReddy K.","year":"2019","unstructured":"AnjiReddy K.; Karpagam S.; Hyperbranched cellulose polyester of oral thin film and nanofiber for rapid release of donepezil; preparation and in vivo evaluation. Int J Biol Macromol 2019,124,871-887","journal-title":"Int J Biol Macromol"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jhep.2007.02.008","volume":"47","author":"Yao P.","year":"2007","unstructured":"Yao P.; Nussler A.; Liu L.; Hao L.; Song F.; Schirmeier A.; Nussler N.; Quercetin protects human hepatocytes from ethanol-derived oxidative stress by inducing heme oxygenase-1 via the MAPK\/Nrf2 pathways. J Hepatol 2007,47(2),253-261","journal-title":"J Hepatol"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.tips.2020.04.008","volume":"41","author":"Benek O.","year":"2020","unstructured":"Benek O.; Korabecny J.; Soukup O.; A perspective on multi-target drugs for Alzheimer\u2019s disease. Trends Pharmacol Sci 2020,41(7),434-445","journal-title":"Trends Pharmacol Sci"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.tifs.2016.07.004","volume":"56","author":"Wang W.","year":"2016","unstructured":"Wang W.; Sun C.; Mao L.; Ma P.; Liu F.; Yang J.; Gao Y.; The biological activities, chemical stability, metabolism and delivery systems of quercetin: A review. Trends Food Sci Technol 2016,56,21-38","journal-title":"Trends Food Sci Technol"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"30373","DOI":"10.1021\/acsami.1c07281","volume":"13","author":"Dou Y.","year":"2021","unstructured":"Dou Y.; Zhao D.; Yang F.; Tang Y.; Chang J.; Natural phyto-antioxidant albumin nanoagents to treat advanced Alzheimer\u2019s disease. ACS Appl Mater Interfaces 2021,13(26),30373-30382","journal-title":"ACS Appl Mater Interfaces"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1166\/jbn.2021.2995","volume":"17","author":"Zhang Y.","year":"2021","unstructured":"Zhang Y.; Wang L.; Li G.; Gao J.; Berberine-albumin nanoparticles: Preparation, thermodynamic study and evaluation their protective effects against oxidative stress in primary neuronal cells as a model of Alzheimer\u2019s disease. J Biomed Nanotechnol 2021,17(6),1088-1097","journal-title":"J Biomed Nanotechnol"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"25543","DOI":"10.1021\/acsomega.0c01295","volume":"5","author":"Shityakov S.","year":"2020","unstructured":"Shityakov S.; Fischer A.; Su K.P.; Hussein A.A.; Dandekar T.; Broscheit J.; Novel approach for characterizing propofol binding affinities to serum albumins from different species. ACS Omega 2020,5(40),25543-25551","journal-title":"ACS Omega"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1080\/17425247.2016.1193149","volume":"13","author":"Karimi M.","year":"2016","unstructured":"Karimi M.; Bahrami S.; Ravari S.B.; Zangabad P.S.; Mirshekari H.; Bozorgomid M.; Shahreza S.; Sori M.; Hamblin M.R.; Albumin nanostructures as advanced drug delivery systems. Expert Opin Drug Deliv 2016,13(11),1609-1623","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"4154","DOI":"10.1021\/acsnano.5b07400","volume":"10","author":"Zhou N.","year":"2016","unstructured":"Zhou N.; Yuan M.; Gao Y.; Li D.; Yang D.; Semiconductor quantum dots. ACS Nano 2016,10(4),4154-4163","journal-title":"ACS Nano"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"110775","DOI":"10.1039\/C6RA24349E","volume":"6","author":"Zhou S.","year":"2016","unstructured":"Zhou S.; Xu H.; Gan W.; Yuan Q.; Graphene quantum dots: Recent progress in preparation and fluorescence sensing applications. RSC Advances 2016,6(112),110775-110788","journal-title":"RSC Advances"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1021\/acschemneuro.0c00273","volume":"11","author":"Tak K.","year":"2020","unstructured":"Tak K.; Sharma R.; Dave V.; Jain S.; Sharma S.; Clitoria ternatea mediated synthesis of graphene quantum dots for the treatment of Alzheimer\u2019s disease. ACS Chem Neurosci 2020,11(22),3741-3748","journal-title":"ACS Chem Neurosci"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"19060","DOI":"10.1039\/C5NR06282A","volume":"7","author":"Liu Y.","year":"2015","unstructured":"Liu Y.; Xu L.P.; Dai W.; Dong H.; Wen Y.; Zhang X.; Graphene quantum dots for the inhibition of &#x3B2; amyloid aggregation. Nanoscale 2015,7(45),19060-19065","journal-title":"Nanoscale"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1021\/acschemneuro.7b00439","volume":"9","author":"Liu Y.","year":"2018","unstructured":"Liu Y.; Xu L.P.; Wang Q.; Yang B.; Zhang X.; Synergistic inhibitory effect of gqds\u2013tramiprosate covalent binding on amyloid aggregation. ACS Chem Neurosci 2018,9(4),817-823","journal-title":"ACS Chem Neurosci"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.2147\/IJN.S68429","volume":"10","author":"Shityakov S.","year":"2015","unstructured":"Shityakov S.; Pastorin G.; Foerster C.; Salvador E.; Blood\u2013brain barrier transport studies, aggregation, and molecular dynamics simulation of multiwalled carbon nanotube functionalized with fluorescein isothiocyanate. Int J Nanomedicine 2015,10,1703-1713","journal-title":"Int J Nanomedicine"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1039\/C8DT03948H","volume":"48","author":"You Y.","year":"2019","unstructured":"You Y.; Wang N.; He L.; Shi C.; Zhang D.; Liu Y.; Luo L.; Chen T.; Designing dual-functionalized carbon nanotubes with high blood\u2013brain-barrier permeability for precise orthotopic glioma therapy. Dalton Trans 2019,48(5),1569-1573","journal-title":"Dalton Trans"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jconrel.2016.01.031","volume":"225","author":"Kafa H.","year":"2016","unstructured":"Kafa H.; Wang J.T.W.; Rubio N.; Klippstein R.; Costa P.M.; Hassan H.A.F.M.; Sosabowski J.K.; Bansal S.S.; Preston J.E.; Abbott N.J.; Al-Jamal K.T.; Translocation of LRP1 targeted carbon nanotubes of different diameters across the blood\u2013brain barrier in vitro and in vivo. J Control Release 2016,225,217-229","journal-title":"J Control Release"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1002\/jbm.a.36743","volume":"107","author":"Liliom H.","year":"2019","unstructured":"Liliom H.; Lajer P.; B&#xE9;rces Z.; Csernyus B.; Szab&#xF3; &#xC1;.; Pinke D.; L\u0151w P.; Fekete Z.; Pongr&#xE1;cz A.; Schlett K.; Comparing the effects of uncoated nanostructured surfaces on primary neurons and astrocytes. J Biomed Mater Res A 2019,107(10),2350-2359","journal-title":"J Biomed Mater Res A"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"5441","DOI":"10.1166\/jnn.2019.16547","volume":"19","author":"Yoo C.J.","year":"2019","unstructured":"Yoo C.J.; Lee U.; Kim Y.J.; Park J.; Yoo Y.M.; Dose-dependent cytotoxicity of gold nanoparticles on human neural progenitor cells and rat brain. J Nanosci Nanotechnol 2019,19(9),5441-5447","journal-title":"J Nanosci Nanotechnol"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"645","DOI":"10.3762\/bjnano.7.57","volume":"7","author":"Song B.","year":"2016","unstructured":"Song B.; Zhang Y.; Liu J.; Feng X.; Zhou T.; Shao L.; Unraveling the neurotoxicity of titanium dioxide nanoparticles: focusing on molecular mechanisms. Beilstein J Nanotechnol 2016,7(1),645-654","journal-title":"Beilstein J Nanotechnol"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"114800","DOI":"10.1016\/j.taap.2019.114800","volume":"385","author":"Bittner A.","year":"2019","unstructured":"Bittner A.; Ducray A.D.; Stoffel M.H.; Felser A.; Mevissen M.; Polymer-coated nanoparticles and their effects on mitochondrial function in brain endothelial cells. Toxicol Appl Pharmacol 2019,385,114800","journal-title":"Toxicol Appl Pharmacol"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"110884","DOI":"10.1016\/j.ecoenv.2020.110884","volume":"202","author":"Wang Z.","year":"2020","unstructured":"Wang Z.; Zhang C.; Liu X.; Huang F.; Wang Z.; Yan B.; Oral intake of ZrO nanoparticles by pregnant mice results in nanoparticles\u2019 deposition in fetal brains. Ecotoxicol Environ Saf 2020,202,110884","journal-title":"Ecotoxicol Environ Saf"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3390\/polym10090983","volume":"10","author":"Vijayan V.","year":"2018","unstructured":"Vijayan V.; Uthaman S.; Park I.K.; Cell membrane-camouflaged nanoparticles: A promising biomimetic strategy for cancer theragnostics. Polymers (Basel) 2018,10(9),983","journal-title":"Polymers (Basel)"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"930","DOI":"10.7150\/thno.14855","volume":"6","author":"Ma Y.","year":"2016","unstructured":"Ma Y.; Mou Q.; Wang D.; Zhu X.; Yan D.; Dendritic polymers for theranostics. Theranostics 2016,6(7),930-947","journal-title":"Theranostics"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jconrel.2019.09.015","volume":"313","author":"Grimaudo M.A.","year":"2019","unstructured":"Grimaudo M.A.; Concheiro A.; Alvarez-Lorenzo C.; Nanogels for regenerative medicine. J Control Release 2019,313,148-160","journal-title":"J Control Release"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"122606","DOI":"10.1016\/j.jhazmat.2020.122606","volume":"399","author":"Liu N.","year":"2020","unstructured":"Liu N.; Tang M.; Toxicity of different types of quantum dots to mammalian cells in vitro: An update review. J Hazard Mater 2020,399(43),122606","journal-title":"J Hazard Mater"}],"container-title":["Current Pharmaceutical Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666221216114912","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/211998\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1381612829666221216114912","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T10:27:53Z","timestamp":1679653673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/211998\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":160,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1381612829666221216114912","relation":{},"ISSN":["1381-6128"],"issn-type":[{"value":"1381-6128","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-06-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}